ClinicalTrials.govpublic full text
Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer
rectal cancer, ugt1a1, liposomal irinotecan, total neoadjuvant therapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 804180
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.